HIGHLIGHTS
- who: Adamantia Nikolaidi from the National Institutes of Health (NIH), United States University of Messina, Italy have published the research: Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges, in the Journal: (JOURNAL)
- what: The study showed that the administration of NACT followed by IDS led to a statistically significant decrease in postoperative complications of Grade 3 and 4. This study demonstrated that NACT was associated with lower level of invasiveness of interval debulking surgery, leading to lower frequency of postoperative adverse events and blood/albumin transfusions, lower frequency of abdominal organ and distant metastases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.